JLK to Supply Brain Imaging AI Solutions to Gyeonggi Provincial Medical Center Anseong Hospital

JLK (CEO Dongmin Kim), a medical artificial intelligence (AI) company, announced on the 17th that it has signed a contract with Gyeonggi Provincial Medical Center Anseong Hospital to supply its brain imaging analysis AI solution. This contract is based on a subscription model, enabling immediate application of JLK's key AI products in the field.

The solutions provided to Anseong Hospital include five CT- and MRI-based brain imaging AI systems, including JLK-PWI. These AI solutions cover everything from emergency stroke assessments to precision diagnosis assistance and treatment decision support. JLK's subscription model allows hospitals to use the AI software on an ongoing basis for a set period of time, and ongoing maintenance and updates ensure stable clinical quality.

The provision of the solution to Anseong Hospital, a regional public hospital with approximately 300 beds, signifies the growing trend of cases in which AI is being used to improve access to healthcare and the quality of public healthcare.

An official from Anseong Hospital stated, "The speed and accuracy of emergency patient diagnosis determines the patient's prognosis and places a significant burden on medical staff. JLK's AI solution can substantially improve the efficiency of the diagnostic process." He added, "It will also contribute to providing consistent quality medical care to local patients and establishing a rapid response system for critically ill patients linked to regional medical centers."

JLK CEO Kim Dong-min said, “This contract demonstrates the full-scale practical use of AI stroke solutions in domestic medical institutions, including public hospitals,” and emphasized, “We will strengthen usability and accessibility so that more hospitals can adopt the latest AI technology through a subscription model.”


  • See more related articles